News

This study compared the N-NAIL diagnostic tool to NAPSI, highlighting results among patients with nail psoriasis.

In this video, the last in a 5-part series, panelists discuss their future outlook on bronchiectasis management.

In this video, the fourth in a 5-part series, panelists discuss who may benefit from brensocatib's approval.

In this video, the third in a 5-part series, panelists discuss data from the phase 3 ASPEN trial.

In this video, the second in a 5-part series, panelists discuss the recent FDA approval of brensocatib.

In this video, the first in a 5-part series, panelists discuss recent advancements in bronchiectasis management.

Perceived changes in glucose metabolism and regulation in turn lead to more severe reported menopausal symptoms.

In this analysis, a variety of alternative therapies for hair loss, such as oils, stem cells, and laser treatments, were highlighted for their potential.

People with PBC and pruritus had a greater negative impact on HRQoL and reduced activity compared to those without pruritus, infrequently using medication.

A brief history of intravitreal implants; where we started and how far we can still go to reduce treatment burden for patients and clinicians alike.

This review highlights phase 3 and long-term data on deucravacitinib therapy for patients with plaque psoriasis.

Orforglipron met the primary and all key secondary endpoints in patients with obesity/overweight and type 2 diabetes, supporting global regulatory submissions.

Study reveals 7 communication strategies clinicians can use to convey allergy risk and guide adrenaline auto-injector decisions in pediatric consultations.

Take a look at 7 major clinical trials to keep an eye on for the upcoming ESC Congress from August 29-September 1, 2025.

Oral supplementation with a novel dietary AGA-P supplement was shown to increase the clinical efficacy of pharmacological treatments for androgenic alopecia.

In a study, ADHD treatments were linked to reduced suicidal behavior, substance misuse, transport accidents, and criminality, but not accidental injuries.

The cross-sectional analysis of NHANES data highlights obesity and overweight’s influence on the development of obesity-related conditions in US youth.

If approved, the investigative therapy could provide a frontline treatment for patients with SAA who do not have matched sibling donors for cell transplantation.

The investigators present pooled findings from the SUNSHINE and SUNRISE trials assessing secukinumab therapy for HS.

An audio recap of the top 5 stories in healthcare news from the week of 08/17-08/

This study highlights a significant link between alopecia areata and autoimmune thyroid disease, assessing a large-scale and diverse population.

Stay updated with the latest healthcare breakthroughs, including FDA news and new cardiology research, in this week's essential news roundup.

A recent analysis utilizing the AHA’s PREVENT equations has found 11.8 million US adults aged 40 to 75 had a 10-year ASCVD risk of 5% or greater.

In this analysis, investigators looked at quality of life data among pediatric patients with atopic dermatitis in Sub-Saharan Africa.

MGH investigators confirmed the reliability of the Drug Allergy History Tool (DAHT), which outperformed EHR documentation in completeness.

This episode highlights the groundbreaking approval of semaglutide for metabolic dysfunction-associated steatohepatitis, as well as GoodRx’s new Ozempic pricing.

In this analysis, evidence which supports a shift in clinical practice using Chinese herbal medicine was explored for atopic dermatitis.

This episode is the final ADCES 2025 recap episode and includes a spotlight on diabetes technology updates.